APOE and atherosclerosis: In the study by Yu et al. [9], Scl-Ac (25 mg/kg, twice weekly) significantly promoted the progression of AA and atherosclerosis and significantly increased the serum levels of inflammatory cytokines and chemokines in ApoE−/− mice with AngII infusion.